
ATS Reports First Quarter Fiscal 2026 Results
First quarter highlights:
Revenues increased 6.1% year over year to $736.7 million.
Net income was $24.3 million compared to $35.3 million a year ago.
Basic earnings per share were 25 cents, compared to 36 cents a year ago.
Adjusted EBITDA 1 was $101.5 million compared to $106.0 million a year ago.
Adjusted basic earnings per share 1 were 41 cents compared to 50 cents a year ago.
Order Bookings 2 were $693 million, 15.2% lower compared to $817 million a year ago.
Order Backlog 2 was $2,068 million, 9.9% higher compared to $1,882 million a year ago.
"Today ATS reported our first quarter results for fiscal 2026, with revenue growth, including contributions from recent acquisitions, and adjusted earnings margins in line with our expectations," said Andrew Hider, Chief Executive Officer ("CEO"). "These results reflect continued focus on our value drivers, the resilience of our business model, and the dedication of our global teams."
As the Company previously announced, Mr. Hider will be stepping down from his role as CEO of ATS and from its Board of Directors to pursue another leadership opportunity. Mr. Hider's final day with ATS is today, which marks a natural transition point after the reporting of first quarter results and the Company's annual meeting of shareholders. Upon Mr. Hider's departure, Ryan McLeod, currently Chief Financial Officer ("CFO"), will assume the role of Interim CEO (see "Leadership Transition" below).
"ATS is well positioned as a leader in automation, supported by our strong presence in growing, diversified end markets, a sizeable, high-quality Order Backlog and the ATS Business Model ("ABM") firmly entrenched within the culture of our decentralized businesses," said Mr. McLeod. "Our leadership team is well prepared to leverage these advantages and drive value during this transition period."
1 Non-IFRS measure: see 'Non-IFRS and Other Financial Measures'.
2 Supplementary financial measure: see 'Non-IFRS and Other Financial Measures'.
Financial results
(In millions of dollars, except per share and margin data)
Three Months Ended
June 29, 2025
Three Months Ended
June 30, 2024
Variance
Revenues
$
736.7
$
694.3
6.1%
Net income
$
24.3
$
35.3
(31.2)%
Adjusted earnings from operations 1
$
78.6
$
86.2
(8.8)%
Adjusted earnings from operations margin 2
10.7%
12.4%
(175)bps
Adjusted EBITDA 1
$
101.5
$
106.0
(4.2)%
Adjusted EBITDA margin 2
13.8%
15.3%
(149)bps
Basic earnings per share
$
0.25
$
0.36
(30.6)%
Adjusted basic earnings per share 1
$
0.41
$
0.50
(18.0)%
Order Bookings 3
$
693
$
817
(15.2)%
As At
June 29
2025
June 30
2024
Variance
Order Backlog 3
$
2,068
$
1,882
9.9%
1 Non-IFRS financial measure - See "Non-IFRS and Other Financial Measures".
2 Non-IFRS ratio - See "Non-IFRS and Other Financial Measures".
3 Supplementary financial measure - See "Non-IFRS and Other Financial Measures".
Leadership Transition
As disclosed on July 7, 2025, with Mr. Hider's departure from ATS, the Board is conducting a thorough search for a permanent CEO. Mr. McLeod, with the full support of ATS' experienced leadership team, is well-positioned to lead the Company during this interim period, with more than 18 years at ATS and five years as CFO. In addition, Anne Cybulski has been appointed as Interim CFO. Ms. Cybulski is a member of ATS' executive team and has been with ATS for 16 years, holding several finance leadership positions during her tenure including in both Global Services and Industrial Automation. Ms. Cybulski has held the role of Vice President and Corporate Controller for the last three years. Ms. Cybulski holds a Chartered Professional Accountant designation.
During the transition period, Mr. McLeod and ATS' senior leadership team will continue to focus on executing the Company's value creation strategy, including performance improvement across all value drivers, underpinned by ATS' decentralized structure, and a commitment to the ABM, and seek to complement organic growth by continuing to cultivate strategic acquisitions.
First quarter summary
First quarter of fiscal 2026 revenues were 6.1% or $42.4 million higher than in the corresponding period a year ago, primarily due to a 4.1% increase from revenues earned by acquired companies and the 3.2% positive impact of foreign exchange translation, partially offset by a year-over-year decrease in organic revenues (revenues excluding contributions from acquired companies and foreign exchange translation) of 1.2%. Revenues generated from construction contracts increased 6.7% or $26.5 million from the prior period primarily due to contributions from acquisitions of $11.1 million and the positive impact of foreign exchange translation. Construction revenues generated in life sciences, consumer products and food & beverage largely mitigated the lower construction revenues generated in transportation which were a result of lower Order Backlog entering the period, primarily related to EV programs. Revenues from services decreased 4.1% or $7.1 million, primarily due to lower after sales service revenues in the transportation market, partially offset by increases in other markets. Revenues from the sale of goods increased 18.0% or $23.0 million primarily due to revenues earned by acquired companies of $15.4 million, in addition to the positive impact of foreign exchange translation.
By market, revenues generated in life sciences increased $50.4 million or 15.3% year over year. This was primarily due to contributions from organic revenue growth on higher Order Backlog entering the quarter, in addition to contributions from acquisitions totalling $14.6 million, and the positive impact of foreign exchange translation. Revenues generated in food & beverage increased $41.7 million or 43.1% from the corresponding period last year due to organic revenue growth on higher Order Backlog entering the quarter, in addition to contributions from acquisitions, and the positive impact of foreign exchange translation. Revenues generated in consumer products increased $36.7 million or 41.8% year over year primarily due to organic revenue growth on higher Order Backlog entering the quarter. Revenues in transportation decreased $84.9 million or 58.8% year over year due to lower Order Backlog entering the quarter, as the prior year included several large EV projects. Revenues in energy decreased $1.5 million or 4.1% year over year due to timing of program execution.
Net income for the first quarter of fiscal 2026 was $24.3 million (25 cents per share basic), compared to net income of $35.3 million (36 cents per share basic) for the first quarter of fiscal 2025. The decrease primarily reflected higher SG&A, stock-based compensation, and net finance costs, partially offset by increased revenues. Adjusted basic earnings per share were 41 cents compared to 50 cents in the first quarter of fiscal 2025 (adjusted basic earnings per share is a non-IFRS financial measure — see "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures").
Depreciation and amortization expense was $37.3 million in the first quarter of fiscal 2026, compared to $37.4 million a year ago.
EBITDA was $95.1 million (12.9% EBITDA margin) in the first quarter of fiscal 2026 compared to $105.0 million (15.1% EBITDA margin) in the first quarter of fiscal 2025. EBITDA for the first quarter of fiscal 2026 included $3.6 million of stock-based compensation expenses due to revaluation, $2.5 million of restructuring charges, and $0.3 million of incremental costs related to acquisition activity. EBITDA for the corresponding period in the prior year included, $1.3 million of incremental costs related to acquisition activity, $1.0 million of acquisition-related fair value adjustments to acquired inventories, and a $1.3 million recovery of stock-based compensation revaluation expenses. Excluding these costs, adjusted EBITDA was $101.5 million (13.8% adjusted EBITDA margin), compared to $106.0 million (15.3% adjusted EBITDA margin) for the corresponding period in the prior year. Lower adjusted EBITDA primarily reflected increased SG&A expenses. EBITDA and adjusted EBITDA are non-IFRS financial measures, and EBITDA margin and adjusted EBITDA margin are non-IFRS ratios — see "Non-IFRS and Other Financial Measures" and "Reconciliation of Non-IFRS Measures to IFRS Measures".
Order Backlog Continuity
(In millions of dollars)
Order Bookings
First quarter of fiscal 2026 Order Bookings were $693 million, a 15.2% year-over-year decrease, reflecting a 20.7% decline in organic Order Bookings, partially offset by 3.1% of growth from acquired companies and 2.4% from positive foreign exchange translation impacts. By market, Order Bookings in life sciences decreased compared to the prior-year period primarily due to timing of customer programs. Order Bookings in food & beverage increased compared to the prior-year period primarily due to contributions from acquired companies, in addition to the positive impact of foreign exchange translation and organic growth. Order Bookings in consumer products increased from the prior period primarily due to timing of customer projects. Order Bookings in transportation decreased compared to the prior-year period, as expected, reflecting reduced investment in EV production by North American transportation customers. Order Bookings in energy increased compared to the prior-year period primarily due to timing of customer projects, specifically for nuclear refurbishment projects.
Trailing twelve month book-to-bill ratio at June 29, 2025 was 1.17:1. Book-to-bill ratio, Order Bookings and organic Order Bookings growth are supplementary financial measures — see "Non-IFRS and Other Financial Measures."
Backlog
At June 29, 2025, Order Backlog was $2,068 million, 9.9% higher than at June 30, 2024, on account of higher Order Backlog in all markets except for transportation, which included several large EV programs a year ago.
Outlook
The life sciences funnel remains strong and diversified, with opportunities in strategic submarkets such as pharmaceuticals, radiopharmaceuticals, and medical devices. Management continues to identify opportunities with both new and existing customers, including those who produce auto-injectors and wearable devices for diabetes and obesity treatments, contact lenses and pre-filled syringes, automated pharmacy solutions, as well as opportunities to provide life science solutions that leverage integrated capabilities from across ATS. While some customers who are reliant on external funding within the laboratory research space are evaluating spending more closely, management has not seen a material impact on its overall life sciences funnel activity to date. Funnel activity in food & beverage remains strong. The Company continues to benefit from strong brand recognition within global tomato processing, as well as other soft fruits and vegetable processing industries. There is also continued demand in automated solutions within the food & beverage market more broadly, in areas such as packaging and secondary processing. Funnel activity in consumer products is stable, although discretionary spending by consumers, influenced by factors such as inflationary pressures, may impact timing of some customer investments in the Company's solutions. In transportation, the funnel consists of smaller opportunities relative to the size of Order Bookings in fiscal years 2023 and 2024. ATS has adjusted its capacity so that it can deploy its specialized capabilities to support customers, particularly in EV, as they adjust their investment requirements, increase platform flexibility and reduce costs. Funnel activity in energy remains strong and includes longer-term opportunities in the nuclear industry. The Company is focused on clean energy applications including solutions for the refurbishment of nuclear power plants, early participation in the small modular reactor market, and grid battery storage.
Customers seeking to de-risk or enhance supply chain resiliency, address skilled worker shortages or combat higher labour costs present ongoing and future opportunities for ATS. Management believes that the underlying trends driving customer demand for ATS solutions, including rising labour constraints, production onshoring or reshoring and the need for scalable, high-quality, energy-efficient production, remain favourable. In addition, funnel growth in markets where sustainability requirements are a focus for customers — including nuclear and grid battery storage, as well as consumer goods packaging — provides ATS with opportunities to use its capabilities to respond to customer needs, including global and regional requirements to reduce carbon emissions.
Order Backlog of $2,068 million is expected to help mitigate some of the impact of quarterly variability in Order Bookings on revenues in the short term. The Company's Order Backlog includes several large enterprise programs that have longer periods of performance and therefore longer revenue recognition cycles, particularly in life sciences. In the second quarter of fiscal 2026, management expects to generate revenues in the range of $700 million to $740 million. This estimate is calculated each quarter based on management's assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity.
Supplier lead times are generally acceptable across key categories; however, inflationary or other cost increases (see "Tariffs"), and price and lead-time volatility may continue to disrupt the timing and progress of the Company's margin expansion efforts and may affect revenue recognition. Over time, achieving management's margin target assumes that the Company will successfully implement its margin expansion initiatives, and that such initiatives will result in improvements to its adjusted earnings from operations margin that offset these shorter-term pressures (see "Forward-Looking Statements" for a description of the risks underlying the achievement of the margin target in future periods).
The timing and geographies of customer capital expenditure decisions on larger opportunities can cause variability in Order Bookings from quarter to quarter (see "Tariffs"). Revenues in a given period are dependent on a combination of the volume of outstanding projects the Company is contracted to perform, the size and duration of those projects, and the timing of project activities including design, assembly, testing, and installation. Given the specialized nature of the Company's offerings, the size and scope of projects vary based on customer needs. The Company seeks to achieve revenue growth organically and by identifying strategic acquisition opportunities that provide access to attractive end-markets and new products and technologies and deliver hurdle-rate returns. After-sales revenues and reoccurring revenues, which ATS defines as revenues from ancillary products and services associated with equipment sales, and revenues from customers who purchase non-customized ATS product at regular intervals, are expected to provide some balance to customers' capital expenditure cycles.
The Company continues to target improvements in non-cash working capital. Over the long term, the Company expects to continue investing in non-cash working capital to support growth, with some fluctuations expected on a quarter-over-quarter basis. The Company's long-term goal is to maintain its investment in non-cash working capital as a percentage of annualized adjusted revenues below 15%. The Company expects that continued cash flows from operations, together with cash and cash equivalents on hand and credit available under operating and long-term credit facilities will be sufficient to fund its requirements for investments in non-cash working capital and capital assets, and to fund strategic investment plans including some potential acquisitions. Acquisitions could result in additional debt or equity financing requirements for the Company. Non-cash working capital as a percentage of adjusted revenues is a non-IFRS ratio — see "Non-IFRS and Other Financial Measures."
The Company continues to make progress in line with its plans to integrate acquired companies, and expects to realize cost and revenue synergies consistent with announced integration plans.
Tariffs
With respect to the evolving environment around proposed and implemented tariffs by the U.S. on goods from various jurisdictions globally, and related international responses, management continues to actively monitor the situation and is taking steps to mitigate risks where possible and is continuing to offer support to customers based on their needs, which may include onshoring or reshoring production. Supply chain impacts resulting from shifting trade dynamics have been largely mitigated through alternative sourcing, along with pricing strategies. While the Company could see impacts over time arising from unmitigated costs related to the tariffs themselves, potential supplier price increases, and the timing and geographic shifts in customers' capital deployment, ATS' global footprint and decentralized operating model, supported by the ABM, provide some flexibility to address potential disruptions over the long term. On a trailing twelve month basis, the Company's equipment and product adjusted revenues from its Canadian and European operations being sold into the U.S. remained consistent with the range previously disclosed (just over 20% of the Company's total adjusted revenues for the year ended March 31, 2025). In addition, the majority of the Company's shipments from Canada into the U.S. fall within the current terms of the US-Mexico-Canada ("USMCA") trade agreement.
Quarterly Conference Call
ATS will host a conference call and webcast at 8:30 a.m. eastern time on Thursday, August 7, 2025 to discuss its quarterly results. The listen-only webcast can be accessed live at www.atsautomation.com. The listen-only webcast can be accessed at https://events.q4inc.com/attendee/857742136 and the conference call can be accessed by dialing (888) 660-6652 five minutes prior and quoting reference number 8782510. A replay of the conference will be available on the ATS website following the call. Alternatively, a telephone recording of the call will be available for one week (until midnight August 14, 2025) by dialing (800) 770-2030 and using the access code 8782510.
About ATS
ATS Corporation is an industry-leading automation solutions provider to many of the world's most successful companies. ATS uses its extensive knowledge base and global capabilities in custom automation, repeat automation, automation products and value-added solutions including pre-automation and after-sales services, to address the sophisticated manufacturing automation systems and service needs of multinational customers in markets such as life sciences, transportation, food & beverage, consumer products, and energy. Founded in 1978, ATS employs approximately 7,500 people at more than 65 manufacturing facilities and over 85 offices in North America, Europe, Asia and Oceania. The Company's common shares are traded on the Toronto Stock Exchange ("TSX") and the New York Stock Exchange ("NYSE") under the symbol ATS. Visit the Company's website at www.atsautomation.com.
Revenues by market
Three Months Ended
June 29, 2025
Three Months Ended
June 30, 2024
Life Sciences
$
378.8
$
328.4
Food & Beverage
138.5
96.8
Consumer Products
124.5
87.8
Transportation
59.5
144.4
Energy
35.4
36.9
Total revenues
$
736.7
$
694.3
Consolidated Operating Results
(In millions of dollars)
Three Months Ended
June 29, 2025
Three Months Ended
June 30, 2024
Earnings from operations
$
57.8
$
67.6
Amortization of acquisition-related intangible assets
14.4
17.6
Acquisition-related transaction costs
0.3
1.3
Acquisition-related inventory fair value charges
—
1.0
Restructuring charges
2.5
—
Mark to market portion of stock-based compensation
3.6
(1.3
)
Adjusted earnings from operations 1
$
78.6
$
86.2
1 Non-IFRS financial measure - See "Non-IFRS and Other Financial Measures".
Three Months Ended
June 29, 2025
Three Months Ended
June 30, 2024
Earnings from operations
$
57.8
$
67.6
Depreciation and amortization
37.3
37.4
EBITDA 1
$
95.1
$
105.0
Restructuring charges
2.5
—
Acquisition-related transaction costs
0.3
1.3
Acquisition-related inventory fair value charges
—
1.0
Mark to market portion of stock-based compensation
3.6
(1.3
)
Adjusted EBITDA 1
$
101.5
$
106.0
1 Non-IFRS financial measure - See "Non-IFRS and Other Financial Measures".
Order Backlog by Market
(In millions of dollars)
As at
June 29
2025
June 30
2024
Life Sciences
$
1,160
$
990
Food & Beverage
229
216
Consumer Products
262
150
Transportation
174
417
Energy
243
109
Total
$
2,068
$
1,882
Reconciliation of Non-IFRS Measures to IFRS Measures
(In millions of dollars, except per share data)
The following table reconciles adjusted EBITDA and EBITDA to the most directly comparable IFRS measure (net income):
Three Months Ended
June 29, 2025
Three Months Ended
June 30, 2024
Adjusted EBITDA
$
101.5
$
106.0
Less: restructuring charges
2.5
—
Less: acquisition-related transaction costs
0.3
1.3
Less: acquisition-related inventory fair value charges
—
1.0
Less: mark to market portion of stock-based compensation
3.6
(1.3
)
EBITDA
$
95.1
$
105.0
Less: depreciation and amortization expense
37.3
37.4
Earnings from operations
$
57.8
$
67.6
Less: net finance costs
25.6
19.5
Less: provision for income taxes
7.9
12.8
Net income
$
24.3
$
35.3
The following table reconciles adjusted earnings from operations, adjusted net income, and adjusted basic earnings per share to the most directly comparable IFRS measures (net income and basic earnings per share):
Three Months Ended June 29, 2025
Three Months Ended June 30, 2024
Earnings from operations
Finance costs
Provision for income taxes
Net income
Basic
EPS
Earnings from operations
Finance costs
Provision for income taxes
Net income
Basic
EPS
Reported (IFRS)
$
57.8
$
(25.6
)
$
(7.9
)
$
24.3
$
0.25
$
67.6
$
(19.5
)
$
(12.8
)
$
35.3
$
0.36
Amortization of acquisition-related intangibles
14.4
—
—
14.4
0.14
17.6
—
—
17.6
0.18
Restructuring charges
2.5
—
—
2.5
0.03
—
—
—
—
—
Acquisition-related inventory fair value charges
—
—
—
—
—
1.0
—
—
1.0
0.01
Acquisition-related transaction costs
0.3
—
—
0.3
—
1.3
—
—
1.3
0.01
Mark to market portion of stock-based
compensation
3.6
—
—
3.6
0.04
(1.3
)
—
—
(1.3
)
(0.01
)
Adjustment to provision for income taxes 1
—
—
(5.2
)
(5.2
)
(0.05
)
—
—
(4.7
)
(4.7
)
(0.05
)
Adjusted (non-IFRS)
$
78.6
$
39.9
$
0.41
$
86.2
$
49.2
$
0.50
1 Adjustments to provision for income taxes relate to the income tax effects of adjustment items that are excluded for the purposes of calculating non-IFRS based adjusted net income.
The following table reconciles organic revenue to the most directly comparable IFRS measure (revenues):
Three Months Ended
June 29, 2025
Three Months Ended
June 30, 2024
Organic revenue
$
685.6
$
658.2
Revenues of acquired companies
28.6
29.9
Impact of foreign exchange rate changes
22.5
6.2
Total revenues
$
736.7
$
694.3
Organic revenue growth
(1.2
)%
The following table reconciles non-cash working capital as a percentage of revenues to the most directly comparable IFRS measures:
As at
June 29
2025
March 31
2025
Accounts receivable
$
522.6
$
719.4
Income tax receivable
16.1
32.1
Contract assets
560.3
503.6
Inventories
310.5
320.2
Deposits, prepaids and other assets
123.7
104.2
Accounts payable and accrued liabilities
(632.4
)
(665.1
)
Income tax payable
(47.7
)
(40.1
)
Contract liabilities
(322.6
)
(330.1
)
Provisions
(27.0
)
(30.0
)
Non-cash working capital
$
503.5
$
614.2
Trailing six-month adjusted revenues annualized
$
2,915.5
$
2,746.1
Working capital %
17.3
%
22.4
%
The following table reconciles net debt to the most directly comparable IFRS measures:
As at
June 29
2025
March 31
2025
Cash and cash equivalents
$
188.6
$
225.9
Bank indebtedness
(2.0
)
(27.3
)
Current portion of lease liabilities
(33.8
)
(32.7
)
Current portion of long-term debt
(0.2
)
(0.2
)
Long-term lease liabilities
(99.6
)
(96.7
)
Long-term debt
(1,383.7
)
(1,543.5
)
Net Debt
$
(1,330.7
)
$
(1,474.5
)
Pro Forma Adjusted EBITDA (TTM)
$
365.9
$
374.4
Net Debt to Pro Forma Adjusted EBITDA
3.6x
3.9x
The following table reconciles free cash flow to the most directly comparable IFRS measures:
Three Months Ended
June 29, 2025
Three Months Ended
June 30, 2024
Cash flows provided by (used in) operating activities
$
155.8
$
(35.4
)
Acquisition of property, plant and equipment
(7.1
)
(7.1
)
Acquisition of intangible assets
(9.2
)
(8.8
)
Free cash flow
$
139.5
$
(51.3
)
Certain non-IFRS financial measures exclude the impact on stock-based compensation expense of the revaluation of RSUs and DSUs resulting specifically from the change in market price of the Company's common shares between periods. Management believes the adjustment provides further insight into the Company's performance.
The following table reconciles total stock-based compensation expense to its components:
(in millions of dollars)
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Total stock-based compensation expense (recovery)
$
8.4
$
(2.3
)
$
5.1
$
2.7
$
3.7
$
(4.3
)
$
4.7
$
3.5
Less: Mark to market portion of stock-based compensation
3.6
(3.4
)
1.4
(1.9
)
(1.3
)
(8.5
)
(0.6
)
(2.0
)
Base stock-based compensation expense
$
4.8
$
1.1
$
3.7
$
4.6
$
5.0
$
4.2
$
5.3
$
5.5
INVESTMENTS, LIQUIDITY, CASH FLOW AND FINANCIAL RESOURCES
(In millions of dollars, except ratios)
As at
June 29
2025
March 31
2025
Cash and cash equivalents
$
188.6
$
225.9
Debt-to-equity ratio 1
0.98:1
1.10:1
1 Debt is calculated as bank indebtedness, long-term debt and lease liabilities. Equity is calculated as total equity less accumulated other comprehensive income.
Three Months Ended
June 29, 2025
Three Months Ended
June 30, 2024
Cash, beginning of period
$
225.9
$
170.2
Total cash provided by (used in):
Operating activities
155.8
(35.4
)
Investing activities
(16.2
)
(15.4
)
Financing activities
(177.0
)
65.2
Net foreign exchange difference
0.1
0.5
Cash, end of period
$
188.6
$
185.1
ATS CORPORATION
Interim Condensed Consolidated Statements of Financial Position
(in thousands of Canadian dollars - unaudited)
As at
June 29
2025
March 31
2025
ASSETS
Current assets
Cash and cash equivalents
$
188,609
$
225,947
Accounts receivable
522,555
719,435
Income tax receivable
16,093
32,065
Contract assets
560,321
503,552
Inventories
310,459
320,172
Deposits, prepaids and other assets
123,690
104,179
1,721,727
1,905,350
Non-current assets
Property, plant and equipment
318,741
325,048
Right-of-use assets
125,815
122,291
Long-term deposits
4,759
4,992
Other assets
10,689
7,062
Goodwill
1,384,348
1,394,576
Intangible assets
732,805
758,531
Deferred income tax assets
109,715
104,022
2,686,872
2,716,522
Total assets
$
4,408,599
$
4,621,872
LIABILITIES AND EQUITY
Current liabilities
Bank indebtedness
$
1,987
$
27,271
Accounts payable and accrued liabilities
632,442
665,109
Income tax payable
47,665
40,073
Contract liabilities
322,649
330,134
Provisions
27,002
29,960
Current portion of lease liabilities
33,774
32,694
Current portion of long-term debt
179
219
1,065,698
1,125,460
Non-current liabilities
Employee benefits
26,428
25,805
Long-term provisions
959
1,000
Long-term lease liabilities
99,587
96,699
Long-term debt
1,383,746
1,543,459
Deferred income tax liabilities
90,227
100,573
Other long-term liabilities
32,934
19,519
1,633,881
1,787,055
Total liabilities
$
2,699,579
$
2,912,515
EQUITY
Share capital
$
839,710
$
842,015
Contributed surplus
40,741
36,539
Accumulated other comprehensive income
152,246
166,855
Retained earnings
674,575
660,368
Equity attributable to shareholders
1,707,272
1,705,777
Non-controlling interests
1,748
3,580
Total equity
1,709,020
1,709,357
Total liabilities and equity
$
4,408,599
$
4,621,872
Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company's profile on SEDAR+ at www.sedarplus.com, the Company's profile on the U.S. Securities and Exchange Commission's website at www.sec.gov, and on the Company's website at www.atsautomation.com.
ATS CORPORATION
Interim Condensed Consolidated Statements of Cash Flows
(in thousands of Canadian dollars - unaudited)
For the three months ended
June 29
2025
June 30
2024
Operating activities
Net income
$
24,266
$
35,327
Items not involving cash
Depreciation of property, plant and equipment
8,404
7,771
Amortization of right-of-use assets
8,953
8,082
Amortization of intangible assets
19,957
21,589
Deferred income taxes
(22,014
)
(4,896
)
Other items not involving cash
(3,443
)
200
Stock-based compensation
4,325
3,403
Change in non-cash operating working capital
115,334
(106,874
)
Cash flows provided by (used in) operating activities
$
155,782
$
(35,398
)
Investing activities
Acquisition of property, plant and equipment
$
(7,094
)
$
(7,106
)
Acquisition of intangible assets
(9,240
)
(8,809
)
Proceeds from disposal of property, plant and equipment
91
517
Cash flows used in investing activities
$
(16,243
)
$
(15,398
)
Financing activities
Bank indebtedness
$
(25,065
)
$
5,399
Repayment of long-term debt
(175,023
)
(6,993
)
Proceeds from long-term debt
45,000
118,664
Proceeds from exercise of stock options
426
60
Purchase of non-controlling interest
(4,370
)
—
Repurchase of common shares
(10,000
)
(44,983
)
Principal lease payments
(7,921
)
(6,950
)
Cash flows provided by (used in) financing activities
$
(176,953
)
$
65,197
Effect of exchange rate changes on cash and cash equivalents
76
508
Increase (decrease) in cash and cash equivalents
(37,338
)
14,909
Cash and cash equivalents, beginning of period
225,947
170,177
Cash and cash equivalents, end of period
$
188,609
$
185,086
Supplemental information
Cash income taxes paid
$
1,989
$
17,226
Cash interest paid
$
20,009
$
23,029
Please refer to complete Interim Condensed Consolidated Financial Statements for supplemental notes which can be found on the Company's profile on SEDAR+ at www.sedarplus.com, the Company's profile on the U.S. Securities and Exchange Commission's website at www.sec.gov, and on the Company's website at www.atsautomation.com.
Non-IFRS and Other Financial Measures
Throughout this document, management uses certain non-IFRS financial measures, non-IFRS ratios and supplementary financial measures to evaluate the performance of the Company.
The terms "EBITDA", "organic revenue", "adjusted net income", "adjusted earnings from operations", "adjusted revenues", "adjusted EBITDA", "pro forma adjusted EBITDA", "adjusted basic earnings per share", and "free cash flow", are non-IFRS financial measures, "EBITDA margin", "adjusted earnings from operations margin", "adjusted EBITDA margin", "organic revenue growth", "non-cash working capital as a percentage of adjusted revenues", and "net debt to pro forma adjusted EBITDA" are non-IFRS ratios, and "operating margin", "Order Bookings", "organic Order Bookings", "organic Order Bookings growth", "Order Backlog", and "book-to-bill ratio" are supplementary financial measures, all of which do not have any standardized meaning prescribed within IFRS and therefore may not be comparable to similar measures presented by other companies. Such measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. In addition, management uses "earnings from operations", which is an additional IFRS measure, to evaluate the performance of the Company. Earnings from operations is presented on the Company's consolidated statements of income as net income excluding income tax expense and net finance costs. Operating margin is an expression of the Company's earnings from operations as a percentage of revenues. EBITDA is defined as earnings from operations excluding depreciation and amortization. EBITDA margin is an expression of the Company's EBITDA as a percentage of revenues. Organic revenue is defined as revenues in the stated period excluding revenues from acquired companies for which the acquired company was not a part of the consolidated group in the comparable period. Organic revenue growth compares the stated period organic revenue with the reported revenue of the comparable prior period. Adjusted earnings from operations is defined as earnings from operations before items excluded from management's internal analysis of operating results, such as amortization expense of acquisition-related intangible assets, acquisition-related transaction and integration costs, restructuring charges, legal settlement costs that arise outside of the ordinary course of business, the mark-to-market adjustment on stock-based compensation and certain other adjustments which would be non-recurring in nature ("adjustment items"). Adjusted earnings from operations margin is an expression of the Company's adjusted earnings from operations as a percentage of revenues. Adjusted revenues are defined as revenues before any adjustment items. Adjusted EBITDA is defined as adjusted earnings from operations excluding depreciation and amortization. Pro forma adjusted EBITDA is adjusted EBITDA on a pro forma basis to reflect full contribution from recent acquisitions. Adjusted EBITDA margin is an expression of the entity's adjusted EBITDA as a percentage of revenues. Adjusted basic earnings per share is defined as adjusted net income on a basic per share basis, where adjusted net income is defined as adjusted earnings from operations less net finance costs and income tax expense, plus tax effects of adjustment items and adjusted for other significant items of a non-recurring nature. Non-cash working capital as a percentage of adjusted revenues is defined as the sum of accounts receivable, contract assets, inventories, deposits, prepaids and other assets, less accounts payable, accrued liabilities, provisions and contract liabilities divided by the trailing two fiscal quarter adjusted revenues annualized. Free cash flow is defined as cash provided by operating activities less property, plant and equipment and intangible asset expenditures. Net debt to pro forma adjusted EBITDA is the ratio of the net debt of the Company (cash and cash equivalents less bank indebtedness, long-term debt, and lease liabilities) to the trailing twelve month pro forma adjusted EBITDA. Order Bookings represent new orders for the supply of automation systems, services and products that management believes are firm. Organic Order Bookings are defined as Order Bookings in the stated period excluding Order Bookings from acquired companies for which the acquired company was not a part of the consolidated group in the comparable period. Organic Order Bookings growth compares the stated period organic Order Bookings with the reported Order Bookings of the comparable prior period. Order Backlog is the estimated unearned portion of revenues on customer contracts that are in process and have not been completed at the specified date. Book to bill ratio is a measure of Order Bookings compared to adjusted revenue.
Following amendments to ATS' RSU Plan in 2022 to provide the Company with the option for settlement in shares purchased in the open market and the creation of the employee benefit trust to facilitate such settlement, ATS began to account for equity-settled RSUs using the equity method of accounting. However, prior RSU grants which will be cash-settled and DSU grants which will be cash-settled are accounted for as described in the Company's annual consolidated financial statements and have volatility period over period based on the fluctuating price of ATS' common shares. Certain non-IFRS financial measures (adjusted EBITDA, net debt to pro forma adjusted EBITDA, adjusted earnings from operations and adjusted basic earnings per share) exclude the impact on stock-based compensation expense of the revaluation of DSUs and RSUs resulting specifically from the change in market price of the Company's common shares between periods. Management believes that this adjustment provides insight into the Company's performance, as share price volatility drives variability in the Company's stock-based compensation expense.
Operating margin, adjusted earnings from operations, adjusted revenues, EBITDA, EBITDA margin, adjusted EBITDA, pro forma adjusted EBITDA and adjusted EBITDA margin are used by the Company to evaluate the performance of its operations. Management believes that earnings from operations is an important indicator in measuring the performance of the Company's operations on a pre-tax basis and without consideration as to how the Company finances its operations. Management believes that adjusted revenues, organic revenue and organic revenue growth, when considered with IFRS measures, allow the Company to better measure the Company's performance and evaluate long-term performance trends. Organic revenue growth also facilitates easier comparisons of the Company's performance with prior and future periods and relative comparisons to its peers. Management believes that EBITDA and adjusted EBITDA are important indicators of the Company's ability to generate operating cash flows to fund continued investment in its operations. Management believes that adjusted earnings from operations, adjusted earnings from operations margin, adjusted EBITDA, adjusted net income and adjusted basic earnings per share are important measures to increase comparability of performance between periods. The adjustment items used by management to arrive at these metrics are not considered to be indicative of the business' ongoing operating performance. Management uses the measure "non-cash working capital as a percentage of adjusted revenues" to assess overall liquidity. Free cash flow is used by the Company to measure cash flow from operations after investment in property, plant and equipment and intangible assets. Management uses net debt to pro forma adjusted EBITDA as a measurement of leverage of the Company. Order Bookings provide an indication of the Company's ability to secure new orders for work during a specified period, while Order Backlog provides a measure of the value of Order Bookings that have not been completed at a specified point in time. Both Order Bookings and Order Backlog are indicators of future revenues that the Company expects to generate based on contracts that management believes to be firm. Organic Order Bookings and organic Order Bookings growth allow the Company to better measure the Company's performance and evaluate long-term performance trends. Organic Order Bookings growth also facilitates easier comparisons of the Company's performance with prior and future periods and relative comparisons to its peers. Book to bill ratio is used to measure the Company's ability and timeliness to convert Order Bookings into revenues. Management believes that ATS shareholders and potential investors in ATS use these additional IFRS measures and non-IFRS financial measures in making investment decisions and measuring operational results.
A reconciliation of (i) adjusted EBITDA and EBITDA to net income, (ii) adjusted earnings from operations to net income, (iii) adjusted net income to net income, (iv) adjusted basic earnings per share to basic earnings per share (v) free cash flow to its IFRS measure components and (vi) organic revenue to revenue, in each case for the three months ended June 29, 2025 and June 30, 2024 is contained in this document (see "Reconciliation of Non-IFRS Measures to IFRS Measures"). This document also contains a reconciliation of (i) non-cash working capital as a percentage of revenues and (ii) net debt to their IFRS measure components, in each case at both June 29, 2025 and March 31, 2025 (see "Reconciliation of Non-IFRS Measures to IFRS Measures"). A reconciliation of Order Bookings and Order Backlog to total Company revenues for the three months ended June 29, 2025 and June 30, 2024 is also contained in this news release (see "Order Backlog Continuity").
Forward-Looking Statements
This news release contains certain statements that may constitute forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws ("forward-looking statements"). All such statements are made pursuant to the "safe harbour" provisions of Canadian provincial and territorial securities laws and the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts regarding possible events, conditions or results of operations that ATS believes, expects or anticipates will or may occur in the future, including, but not limited to: the value creation strategy; the Company's strategy to expand organically and through acquisition, and the expected benefits to be derived; disciplined acquisitions; various market opportunities for ATS; expanding in emerging markets; conversion of opportunities into Order Bookings; the announcement of new Order Bookings and the anticipated timeline for delivery; potential impacts on the time to convert opportunities into Order Bookings; the Company's Order Backlog partially mitigating the impact of variable Order Bookings; the expected benefits where the Company engages with customers on enterprise-type solutions; the potential impact of the Company's approach to market and timing of customer decisions on Order Bookings, performance period, and timing of revenue recognition; collection of payments from customers; expected benefits with respect to the Company's efforts to grow its product portfolio and after-sale service revenues; the ability of after-sales revenues and reoccurring revenues to provide some balance to customers' capital expenditure cycles; initiatives in furtherance of the Company's goal of improving its adjusted earnings from operations margin over the long term; the uncertainty of supply chain dynamics; the anticipated range of revenues for the following quarter; expectation of realization of cost and revenue synergies from integration of acquired businesses; non-cash working capital levels as a percentage of revenues in the short-term and the long-term; the expectation to continue investing in non-cash working capital to support growth; planned reorganization activities; expectation in relation to meeting liquidity and funding requirements for investments; potential to use debt or equity financing to support strategic opportunities and growth strategy; underlying trends driving customer demand; potential impacts of variability in bookings caused by the timing and geographies of customer capital expenditure decisions on larger opportunities; the ability to achieve revenue growth organically and by identifying strategic acquisition opportunities; expected capital expenditures for fiscal 2026; the uncertainty and potential impact on the Company's business and operations due to the current macroeconomic environment including the impacts of inflation, uncertainty caused by the supply chain dynamics, interest rate changes, international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures, and regional conflicts; and the Company's belief with respect to the outcome or impact of any lawsuits, claims, counterclaims and contingencies.
Forward-looking statements are inherently subject to significant known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of ATS, or developments in ATS' business or in its industry, to differ materially from the anticipated results, performance, achievements, or developments expressed or implied by such forward-looking statements. Important risks, uncertainties, and factors that could cause actual results to differ materially from expectations expressed in the forward-looking statements include, but are not limited to: the impact of regional or global conflicts; general market performance including capital market conditions and availability and cost of credit; risks related to the international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures, and any further escalation of such trade disputes; risks related to a recession, slowdown, and/or sustained downturn in the economy; performance of the markets that ATS serves; industry challenges in securing the supply of labour, materials, and, in certain jurisdictions, energy sources such as natural gas; impact of inflation; interest rate changes; foreign currency and exchange risk; the relative weakness of the Canadian dollar; risks related to customer concentration; risks related to any customer disagreements; impact of factors such as increased pricing pressure, increased cost of energy and supplies, and delays in relation thereto, and possible margin compression; the regulatory and tax environment; the emergence of new infectious diseases or any epidemic or pandemic outbreak or resurgence, and collateral consequences thereof, including the disruption of economic activity, volatility in capital and credit markets, and legislative and regulatory responses; the impacts of inflation, uncertainty caused by the supply chain dynamics, interest rate changes, international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures, and regional conflicts that have in the past and may in the future lead to significant price and trading fluctuations in the market price for securities in the stock markets, including the TSX and the NYSE; energy shortages and global prices increases; inability to successfully expand organically or through acquisition, due to an inability to grow expertise, personnel, and/or facilities at required rates or to identify, negotiate and conclude one or more acquisitions; or to raise, through debt or equity, or otherwise have available, required capital; that the ATS Business Model ('ABM") is not effective in accomplishing its goals; that ATS is unable to expand in emerging markets, or is delayed in relation thereto, due to any number of reasons, including inability to effectively execute organic or inorganic expansion plans, focus on other business priorities, or local government regulations or delays; that the timing of completion of new Order Bookings is other than as expected due to various reasons, including schedule changes or the customer exercising any right to withdraw the Order Booking or to terminate the program in whole or in part prior to its completion, thereby preventing ATS from realizing on the full benefit of the program; that some or all of the sales funnel is not converted to Order Bookings due to competitive factors or failure to meet customer needs; that the market opportunities ATS anticipates do not materialize or that ATS is unable to exploit such opportunities; failure to convert Order Backlog to revenue and/or variations in the amount of Order Backlog completed in any given quarter; timing of customer decisions related to large enterprise programs and potential for negative impact associated with any cancellations or non-performance in relation thereto; that the Company is not successful in growing its product portfolio and/or service offering or that expected benefits are not realized; that efforts to improve adjusted earnings from operations margin over long-term are unsuccessful, due to any number of reasons, including less than anticipated increase in after-sales service revenues or reduced margins attached to those revenues, inability to achieve lower costs through supply chain management, failure to develop, adopt internally, or have customers adopt, standardized platforms and technologies, inability to maintain current cost structure if revenues were to grow, and failure of ABM to impact margins; that after-sales or reoccurring revenues do not provide the expected balance to customers' expenditure cycles; that revenues are not in the expected range; that acquisitions made are not integrated as quickly or effectively as planned or expected and, as a result, anticipated benefits and synergies are not realized; non-cash working capital as a percentage of revenues operating at a level other than as expected due to reasons, including, the timing and nature of Order Bookings, the timing of payment milestones and payment terms in customer contracts, and delays in customer programs; that planned reorganization activity does not succeed in improving the cost structure of the Company, or is not completed at the cost or within the timelines expected, or at all; underlying trends driving customer demand will not materialize or have the impact expected; that capital expenditure targets are increased in the future or the Company experiences cost increases in relation thereto; risk that the ultimate outcome of lawsuits, claims, and contingencies give rise to material liabilities for which no provisions have been recorded; the consequence of activist initiatives on the business performance, results, or share price of the Company; the impact of analyst reports on price and trading volume of ATS' shares; and other risks and uncertainties detailed from time to time in ATS' filings with securities regulators, including, without limitation, the risk factors described in ATS' annual information form for the fiscal year ended March 31, 2025, which are available on the System for Electronic Data Analysis and Retrieval+ (SEDAR+) at www.sedarplus.com and on the U.S. Securities Exchange Commission's Electronic Data Gathering, Analysis and Retrieval System (EDGAR) at www.sec.gov. ATS has attempted to identify important factors that could cause actual results to materially differ from current expectations, however, there may be other factors that cause actual results to differ materially from such expectations.
Forward-looking statements are necessarily based on a number of estimates, factors, and assumptions regarding, among others, management's current plans, estimates, projections, beliefs and opinions, the future performance and results of the Company's business and operations; the ability of ATS to execute on its business objectives; the effectiveness of ABM in accomplishing its goals; the ability to successfully implement margin expansion initiative; management's assessment as to the project schedules across all customer contracts in Order Backlog, faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity; initiatives in furtherance of the Company's goal of improving its adjusted earnings from operations margin over the long term; the anticipated growth in the life sciences, food & beverage, consumer products, and energy markets; the ability to seek out, enter into and successfully integrate acquisitions; ongoing cost inflationary pressures and the Company's ability to respond to such inflationary pressures; the effects of foreign currency exchange rate fluctuations on its operations; the Company's competitive position in the industry; the Company's ability to adapt and develop solutions that keep pace with continuing changes in technology and customer needs; the ability to maintain mutually beneficial relationships with the Company's customers; and general economic and political conditions, and global events, including any epidemic or pandemic outbreak or resurgence, and the international trade disputes sparked by tariffs and retaliatory tariffs or other non-tariff measures, and any further escalation of such trade disputes.
Forward-looking statements included in this news release are only provided to understand management's current expectations relating to future periods and, as such, are not appropriate for any other purpose. Although ATS believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and ATS cautions you not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. ATS does not undertake any obligation to update forward-looking statements contained herein other than as required by law.
Certain forward-looking information included in this news release may also constitute a "financial outlook" within the meaning of applicable securities laws. Financial outlook involves statements about ATS' prospective financial performance, financial position or cash flows that is based on and subject to the assumptions about future economic conditions and courses of action described above as well as management's assessment of project schedules across all customer contracts in Order Backlog, expectations for faster-turn product and services revenues, expected delivery timing of third-party equipment and operational capacity. Such assumptions are based on management's assessment of the relevant information currently available and any financial outlook included herein is provided for the purpose of helping readers understand management's current expectations and plans for the future as of the date hereof. The actual results of ATS' operations may vary from the amounts set forth in any financial outlook and such variances may be material. Readers are cautioned that reliance on any financial outlook may not be appropriate for other purposes or in other circumstances and that the risk factors described above and other factors may cause actual results to differ materially from any financial outlook.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
an hour ago
- Globe and Mail
HCI Group (HCI) Q2 EPS Jumps 22%
HCI Group (NYSE:HCI), a property and casualty insurance company with a heavy focus on the Florida market, reported earnings for the second quarter of 2025 on August 7, 2025. In the latest Q2 2025 results, HCI Group beat expectations on both headline earnings (GAAP EPS of $5.18 vs. estimate of $4.52) and revenue (GAAP revenue of $302.6 million vs. estimate of $218.98 million). EPS (GAAP) reached $5.18, compared to the analyst estimate of $4.52. Gross premiums earned (GAAP) were $302.6 million, up from $263.6 million in Q2 2024. These results highlight substantial improvement in underwriting profitability and operational performance. The company also reaffirmed the pending separation of its technology affiliate Exio and maintained its quarterly dividend. Overall, the period reflects strong growth, margin expansion, and continued strategic progress. Source: Analyst estimates for the quarter provided by FactSet. About the Business and Recent Focus Areas HCI Group operates as a diversified insurance and technology business, with most revenue coming from property insurance policies in Florida and other states. Its portfolio spans homeowners, condominium, and specialty insurance, plus a growing footprint in technology and select real estate investments. The company has a strong focus on underwriting discipline and the use of its proprietary claims processing and risk assessment technology. Recently, the company has prioritized growing its technology division (Exio), strengthening risk management, and expanding its core insurance segments. Key success factors include effective catastrophe risk management, regulatory compliance, and leveraging technology for underwriting and operational efficiencies. Strategic expansion has included launching new products and entering fresh geographic markets. Quarter Review: Financial and Operational Performance Pre-tax income (GAAP) increased to $94.4 million, up from $76.0 million in Q2 2024, while net income after noncontrolling interests rose to $66.2 million from $54.1 million in Q2 2024. Book value per share reached $58.55 at June 30, 2025, up from $42.72 at June 30, 2024. This growth in equity reflects both earnings retention and the benefit of lower-than-average catastrophe claims experience. Core insurance operations showed premium growth and improved profitability. Total gross written premiums reached $356.5 million, up from $306.9 million in Q2 2024. Major contributors included Homeowners Choice at $227.1 million (from $191.8 million) in gross written premiums. and TypTap Insurance, HCI's technology-driven homeowners insurance product, which grew to $110.4 million (from $79.1 million) in gross written premiums. Tailrow Reciprocal Exchange, a new home insurance entity launched in February 2025, contributed $5.2 million in gross written premiums as it began its rollout. The gross loss ratio improved to 21.3%, down from 29.7% in Q2 2024. The gross loss ratio measures insurance losses and claims expenses as a percentage of premiums earned; a lower figure suggests higher underwriting profitability. Management credited the improvement to lower claims and litigation frequency. However, they cautioned that gross loss ratios could move back up to the 24–25% range if claim volumes normalize. Across segments, TypTap and Tailrow helped drive premium and revenue growth. Premiums ceded to reinsurance rose, reflecting both higher overall premium volume and continued risk mitigation for hurricane exposures. Policy acquisition and underwriting expenses increased in line with growth, reaching $30.6 million (from $23.5 million), while general and administrative expenses (GAAP) were $20.0 million (from $17.5 million in Q2 2024). There was no adverse development in insurance reserves, and ongoing compliance reviews by regulators, including a financial examination by the Florida Department of Financial Services, were noted. The quarter also saw a substantial reduction in long-term debt as the company converted its 4.75% convertible notes, strengthening the balance sheet by reducing leverage and improving capital flexibility. A major strategic initiative in the quarter was progress on the planned separation of Exio, the technology division. Exio is a software platform used to enhance efficiency in HCI's underwriting functions, and it operates a transaction-based revenue model. Exio's reported stand-alone revenue in Q1 2025 was $52 million, with $24 million in pre-tax income. The spin-off, which is targeted for completion by year end, is expected to unlock new opportunities for Exio to partner with third-party insurance carriers outside the HCI umbrella. The quarterly dividend was maintained at $0.40 per share, unchanged from the same period last year. Looking Ahead Management did not provide detailed numerical guidance for the remainder of fiscal 2025. Leadership commented that the company expects to continue making progress on its key initiatives, especially the Exio spin-off, which is on track for late in the year and seen as a way to support further capital growth and technological expansion. In the near term, investors should watch for developments related to the Exio spin-off and further expansion of TypTap and Tailrow. Catastrophe loss experience and reinsurance costs will also affect results, particularly as hurricane season progresses. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,046%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025


Globe and Mail
an hour ago
- Globe and Mail
Rani (RANI) Q2 Net Loss Improves 16%
Key Points No revenue was reported, in line with expectations. Cash, cash equivalents, and marketable securities declined from $27.6 million as of December 31, 2024, to $10.2 million as of June 30, 2025. These 10 stocks could mint the next wave of millionaires › Rani Therapeutics (NASDAQ:RANI), a biotech company developing oral biologic drug delivery technology, released its earnings for the second quarter of fiscal 2025 on August 7, 2025. Marking an improvement from the prior year period's $(0.26) GAAP result. The company reported no revenue, matching expectations. An overall assessment of the quarter shows progress in pipeline and partnerships, but persistent financial strain and no commercial revenue remain key themes for the period. Metric Q2 2025 Q2 2025 Estimate Q2 2024 Y/Y Change EPS (GAAP) $(0.18) $(0.28) $(0.26) -30.8 % Revenue (GAAP) $0 $0 $0 N/A Research & Development Expense $5.5 million $6.1 million (9.8 %) General & Administrative Expense $5.0 million $6.4 million (21.9 %) Net Loss (GAAP) $(11.2 million) $(13.4 million) -16.4 % Source: Analyst estimates for the quarter provided by FactSet. Company Overview and Recent Focus Rani Therapeutics is focused on enabling the oral delivery of biologic drugs, which are medications typically given by injection due to their complexity and sensitivity. Its main technology, the RaniPill capsule, aims to deliver these drugs through the digestive system, aiming for similar efficacy as injection-based treatments. Recently, the company has concentrated on advancing clinical candidates using its RaniPill system, securing strategic research partnerships, and actively managing costs amid ongoing financial challenges. Success for Rani depends on demonstrating safety and efficacy in clinical trials, creating alliances with established drug makers, and managing cash through incremental fundraising while awaiting regulatory milestones. Quarter Highlights: Financials, Pipeline, and Operations The quarter showed no revenue, as all product candidates remain in pre-launch development stages. Net loss (GAAP) improved year over year, narrowing to $(11.2) million from $(13.4) million. The primary driver was reduced spending: Research and development expenses fell to $5.5 million, down $0.6 million, due to lower compensation costs. General and administrative costs (GAAP) dropped to $5.0 million, reflecting reduced third-party services and lower compensation. Cash, cash equivalents, and marketable securities totaled $10.2 million as of June 30, 2025, a significant reduction from $27.6 million as of December 31, 2024. The company raised $4.3 million in May 2025 through a warrant inducement and another $3.0 million in July 2025 through an equity offering. However, Current liabilities of $20.6 million continue to exceed current assets of $11.1 million, resulting in a stockholders' deficit of $(9.2) million. On the research and development front, Rani announced a new preclinical collaboration with Chugai to test two undisclosed biologic molecules using the RaniPill system, with the agreement entered in August 2024. Separately, at ENDO 2025, the company presented data showing that its RT-114 candidate -- an oral, dual GLP-1/GLP-2 (glucagon-like peptide 1 and 2) receptor agonist -- achieved similar results to injectable forms in canine models. GLP-1 and GLP-2 therapeutics are being researched for obesity treatment, a large and competitive market. In terms of pipeline progress, Rani is planning to initiate a Phase 1 clinical trial for RT-114 in the second half of 2025, marking an important milestone for its oral delivery ambitions. These product advances aim to validate the RaniPill technology in humans and add value through drug pipeline expansion. Looking Ahead: Management Outlook and Investor Focus Management reiterated plans to begin Phase 1 clinical studies for RT-114 for obesity in the second half of 2025. No guidance was given for anticipated revenue or profitability beyond this clinical milestone, and no formal financial outlook was offered. RANI does not currently pay a dividend. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,046%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. *Stock Advisor returns as of August 4, 2025


Globe and Mail
an hour ago
- Globe and Mail
Alarmcom (ALRM) Q2 Revenue Jumps 9%
Key Points Non-GAAP EPS reached $0.60 for Q2 2025, surpassing the non-GAAP EPS estimate of $0.51 and up from $0.58 in Q2 2024 (non-GAAP). Revenue (GAAP) grew to $254.3 million in Q2 2025, exceeding the $243.96 million GAAP estimate and rising 8.8% year over year for total revenue (GAAP). Full-year 2025 guidance for SaaS and license revenue, total revenue, and non-GAAP adjusted EBITDA was raised. These 10 stocks could mint the next wave of millionaires › (NASDAQ:ALRM), a connected property technology provider known for its cloud-based security and automation solutions, reported its Q2 2025 earnings on August 7, 2025. The highlights were an $0.09 earnings per share beat on non-GAAP EPS, which stood at $0.60 versus the $0.51 consensus, and total revenue (GAAP) of $254.3 million, surpassing the $243.96 million estimate. The results showed GAAP revenue up 8.8% from the prior year, and Non-GAAP EPS increased from $0.58 to $0.60 year over year. The company also raised its outlook for FY2025 SaaS and license revenue, total revenue, and non-GAAP adjusted EBITDA. While core SaaS growth and margins remained robust, the newly updated guidance points to moderating expansion in the coming quarters, and Cash flow from operating activities declined significantly year over year, falling to $46.8 million for the first six months of 2025 from $72.8 million for the first six months of 2024. Overall, the quarter reflected solid execution with some new risks emerging. Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. Company Profile and Recent Strategic Priorities offers cloud-based services for residential and commercial properties. Its core platform connects security systems, video cameras, thermostats, lights, and other devices. Security dealers and commercial integrators deploy these solutions to property owners who then use them to monitor and manage their premises from anywhere. Recently, the business has focused on three critical success factors: scaling its cloud platform, expanding its service provider network, and investing in innovation such as AI-based video analytics. International growth and new product launches in commercial and energy management are also at the forefront as it positions itself to serve broader markets and diversify its customer base. Quarter Review: Sales, Margin Dynamics, and Operational Highlights The quarter demonstrated notable progress in multiple areas, with results again exceeding Wall Street expectations, with non-GAAP EPS of $0.60 surpassing the analyst estimate of $0.51. Non-GAAP earnings per share landed at $0.60, above the $0.51 consensus, while Total revenue (GAAP) also topped estimates. Core SaaS and license revenue--which makes up recurring business--grew 9.0% year-over-year, fueled by new deployments and retention in commercial segments. On the hardware side, although management flagged some risk from tariffs that are likely to affect hardware costs and pricing in the second half of 2025. Margins expanded compared to last year. Adjusted EBITDA (non-GAAP) rose 13.0% to $48.4 million. while hardware margins continued to face pressure due to external tariffs and decisions to pass costs through to customers. Research and development spending climbed to $69.1 million as the company kept up investment in new technologies, including AI-driven video analytics and smart energy management devices like the T25 smart thermostat. As a share of revenue, R&D spending ticked slightly lower year over year. Management noted international business grew faster than domestic operations, with particular momentum in Latin America and Europe. Commercial and international sources together make up over a quarter (26%) of SaaS and license revenue and are both growing at around 25% annually. Conversely, growth in North American residential slowed, acting as a drag on consolidated SaaS expansion. Cash flow trends diverged from income and revenue growth. Operating cash flow (GAAP) for the six months ended June 30, 2025 dropped 35.7% compared to the prior year, and Non-GAAP free cash flow fell 47% compared to the first six months of 2024. The decline stemmed partly from higher investment, including a $23.4 million acquisition, and more capital tied up in inventory and expansion. The company ended the quarter with $1.02 billion in cash and equivalents, still ample but down from $1.22 billion in December 2024. Total debt was close to $986.5 million as of June 30, 2025. The company launched several notable products and upgrades during the quarter. OpenEye, commercial video subsidiary, began offering advanced artificial intelligence video analytics, allowing faster cross-camera searches by visual attributes such as individuals or vehicles. There was also the introduction of the T25 smart thermostat, which supports energy management and broad compatibility. Both launches show continued product pipeline momentum and potential for additional recurring revenue through upselling to existing customers. Looking Ahead: Guidance and Key Watchpoints raised its financial guidance for the year. For the current (third) quarter, SaaS and license revenue is expected to be between $171.4 million and $171.6 million. For the full year, the company now anticipates SaaS and license revenue of $681.0 million to $681.4 million (previously $675.8 million to $676.2 million). Total revenue (GAAP) guidance increased to $990.0 million to $996.4 million. The full-year outlook for non-GAAP adjusted EBITDA is now projected at $195.0 million to $196.5 million. Adjusted diluted EPS (non-GAAP) is now estimated at $2.40, based on about 60.3 million shares. However, Management signaled that SaaS and license revenue growth will slow in the second half of 2025 to mid-single-digit percentages, a step down from the nearly 9% rate recorded year to date. The slowdown is attributed to unusually strong first-half results in 2025, including a big contribution from annual contracts in the EnergyHub business and higher-than-normal customer retention, which are not expected to recur in the same way. The company also built some caution into hardware guidance to account for potential volatility tied to tariffs, hardware cost inflation, and macroeconomic factors. Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted. Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,046%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025